drugset / Trial / NCT04235985

Evaluation of Chlorhexidine Gluconate Concentration on Skin of Human Subjects Following Multiple Application Times

NCT04235985

Phase 4 Completed 26 enrolled Molnlycke Health Care AB
NaSingle-groupOpen-labelOther

Summary

This study will evaluate the amount of chlorhexidine gluconate (CHG) present on treated skin of human volunteers following different application times with a test material bathing system. The amount of recovered CHG that resides on the skin following each of the evaluated application times will be evaluated via high performance liquid chromatography with ultraviolet detection (HPLC-UV) and correlated with the MIC values determined separately.

Timeline

Start
2020-01-23
Primary completion
2020-04-02
Completion
2020-04-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine gluconate Other / unclassified 4 % Topical

Indications

No indication recorded.